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INTRODUCTION:  The  most  common  mesenchymal  tumour  of  the  gastrointestinal  tract  is  stromal  tumours
(GISTs).  Symptomatic  GISTs  can  present  with  complications  such  as haemorrhage,  obstruction  and  per-
foration.  Complete  surgical  resection  with  negative  margins  is  the  mainstay  of treatment  but  may  be
imprudent  on emergent  occasion.  Tyrosine-kinase  inhibitors  (TKIs)  have  been  revolutionary  in the treat-
ment  of  GISTs  and  have  resulted  in  improved  outcomes.
PRESENTATION  OF  CASE:  A 41 year old  HIV  positive  male  presented  with  an  acute  history  of  abdominal
pain  and  obstructive  symptoms.  Clinical  examination  revealed  sepsis  and  peritonitis.  One  of the  several
small  bowel  tumours  discovered  at exploratory  laparotomy  was necrotic  and  perforated.  The  perforated
tumour  alone  was  resected  and  a  small  bowel  internal  hernia  reduced.  The  patient  made  an  uneventful
recovery  and  will  be  considered  for TKI  therapy  with  a  view  to later  re-operation.
DISCUSSION:  GISTs  very  rarely  perforate.  The  pathophysiology  of  stromal  tumour  necrosis  is poorly  under-
stood. Multifocality  and  small  bowel  location  are  poor prognosticators  and  may  occur  in the  setting  of
familial  GISTs,  speciﬁc  syndromes  and sporadic  cases.  There  is  no established  association  between  HIV
and  GISTs.
CONCLUSION:  Perforation  occurs  infrequently  in  ≤8%  of symptomatic  cases  and  poses  increased  risk  of
local  recurrence.  The  surgical  management  of  perforation  takes  precedence  in  an  emergency.  The  surgeon
must however  take  cognisance  of  the adherence  to ideal oncologic  principles  where feasible.  TKI therapy
is  invaluable  if a  re-exploration  is  to be later  considered.
©  2014  The  Author.  Published  by  Elsevier  Ltd.  on behalf  of Surgical  Associates  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction1–3
Gastrointestinal stromal tumours (GISTs) are the most common
esenchymal tumours of the gastrointestinal tract. Developments
n tissue evaluation with speciﬁc reference to immunohistochem-
stry and molecular analysis have led to a deeper understanding of
he lesions previously considered to be neurogenic or smooth mus-
le in origin. Small bowel is involved in 30% of cases, second only
o the stomach (60%). 25% of GISTs are asymptomatic and inciden-
ally discovered. Symptomatic GISTs have the potential to present
ith catastrophic complications. 10–20% of GISTs have metastatic
isease upon initial diagnosis. Complete resection with a 1–2 cm
egative margin is the mainstay of treatment. Routine regional
ymphadenectomy is unnecessary. The role of chemoradiother-
py has been disappointing. Tyrosine-kinase inhibitors (TKIs) have
mproved survival and reduced local recurrence rates.
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http://creativecommons.org/licenses/by-nc-nd/3.0/).The aim of this paper is to describe a rare case of multifocal
small bowel GIST presenting with peritonitis secondary to tumour
necrosis and to address the surgical issues relating thereto.
2. Case presentation
A 41 year old male presented with a one day history of severe
generalised abdominal pain associated with bile-stained vomiting.
He denied antecedent trauma, surgery or a family history of gas-
trointestinal malignancy. The patient was HIV positive. Clinical
examination revealed a septic patient with a distended and gen-
erally peritonitic abdomen. Neuroﬁbromas and other syndromic
features were absent. Blood proﬁle conﬁrmed a leucocytosis and
the abdominal radiograph showed features consistent with small
bowel obstruction (Fig. 1).
An exploratory laparotomy via a midline incision was made
(Figs. 2 and 3). Multiple small bowel exophytic masses were dis-
covered, one of which was necrotic and perforated. Large ﬁrm
mesenteric lymph nodes were present. No masses were found in
the remainder of the intra-abdominal gastrointestinal tract and the
liver was free of metastatic spread.
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Erect abdominal radiograph showing distended small bowel loops.
Fig. 2. Small bowel volvulus with internal herniation through omental defect. Large
associated hanging small bowel tumour is noted.
Fig. 3. Trio of exophytic small bowel tumours. Central tumour necrosis is evident.
Table 1
GIST immunohistochemical markers.5,8
Marker Positivity
KIT (CD117) 100%
CD34 70%
SMA  20–30%
S-100 10%
Desmin <5%
Table 2
GIST poor prognostic factors.1,3,5,8,10
Size (>10 cm)  Mitotic index
Anatomical location Advanced/metastatic disease
Rupture/perforation Multifocality
Exon 9 mutation Age extremes
The necrotic mass was amputated at its base and the small bowel
defect closed primarily. Thorough peritoneal irrigation preceded
routine abdominal closure.
3. Discussion1–4
GISTs are unique mesenchymal tumours arising from the inter-
stitial cells of Cajal and occur anywhere from oesophagus to
anorectum. CD117 mutations are characteristic (Table 1). Lymph
node and metastatic disease generally appear late. Multifocality,
perforation and small bowel location are poor prognosticators
present in our patient.5 Accepted poor prognosticators are listed in
Table 2. No association between HIV and GISTs has been established
and it is believed to be purely incidental in this instance.
GISTs display a multitude of presentations depending on site
and up to 40% are discovered upon a gastrointestinal bleed.6 Per-
foration and subsequent peritonitis are exceedingly rare. Tumour
necrosis and perforation is poorly understood but is nevertheless
theorised to occur from replacement of bowel wall with tumour
cells followed by ischaemia from tumour embolisation.7 Perfora-
tion is associated with higher rates of local recurrence and reduces
5-year survival to 24%.5,7,8
Multifocal small bowel GISTs has been described in the setting
of familial GISTs, speciﬁc syndromes (viz. neuroﬁbromatosis type
1 and the Carney-Stratakis Syndrome) and sporadic cases.9 Adult
multifocal sporadic GISTs occur in 11% of all multifocal disease, have
a predilection for small bowel and stomach and generally display
CD117 and CD34 positivity.10
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Table  3
Modiﬁed NIH criteria.1
Tumour characteristics
Diameter (cm) Mitotic count
(per 50HPFs)
Location
Very low risk <2 ≤5 Any
Low risk 2.1–5 ≤5 Any
Intermediate risk ≤5 6–10 Gastric
Intermediate risk 5.1–10 ≤5 Gastric
High risk >10 Any Any
High risk Any size >10 Any
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cHigh risk >5 >5 Any
High risk ≤5 >5 Not gastric
High risk 5.1–10 ≤5 Not gastric
When pre-operative evaluation is possible, small bowel GISTs
hould be assessed with a CT scan, enteroscopy or capsule
ndoscopy. Endoscopic biopsy may  be precluded by technical
actors relating to submucosal tumour position.11 Percutaneous
iopsy risks tumour seeding and must be avoided unless the
umour is irresectable or there is radiologic diagnostic doubt.4,8
omplicated GISTs (haemorrhage, obstruction, perforation) war-
ant urgent open surgical exploration of the abdomen.
Intraoperatively, a decision is made to completely resect all
umours with negative margins where possible. An abbreviated
rocedure is selectively advocated if the patient is critically ill; liver
nd peritoneal metastases, synchronous gastrointestinal masses
nd complications are present.8 In this scenario, the surgeon aims
is-a-vis to acquire tissue for diagnosis with a view to tyrosine-
inase inhibitor therapy initiation on an adjuvant basis. Careful
umour handling cannot be over-emphasised as rupture increases
he risk of local recurrence. Distilled water has cytolytic properties
nd is recommended for peritoneal irrigation in cases of rupture
nd perforation.7 Re-operation is considered if there is a positive
athological response to TKIs.
Imatinib mesylate has drastically improved survival in patients
ith GISTs, especially in c-KIT positive patients. Adjuvant therapy
s currently administered for three years if there is high histolog-
cal potential for malignancy adjudged by the Modiﬁed National
nstitute of Health (NIH) criteria (Table 3). Resistance to TKIs is an
volving problem mainly relating to new mutation development.11
trategies to combat resistance include dose escalation and use of
econd or third-line agents.
. Conclusion
GISTs present with perforation in ≤8% of symptomatic
atients.12 Furthermore, concurrent internal herniation has been
eported on only one prior occasion.13 Urgent surgical exploration
f the abdomen must be directed to the restoration of physio-
ogic homeostasis and tissue acquisition. The principal goal of an
0 resection of all tumours in an emergent situation is surpassed
nless the patient’s condition and tumour burden permits a longer
peration. TKI therapy and re-operation is a sound surgical strategy.
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